Select Committee

Enterprise Research Centre

SMEF0064 - SME Finance

Written Evidence Nov. 09 2023

Committee: Treasury Committee (Department: HM Treasury)

Found: ERC research found that pre-screening by platforms was efficient, as risk grades were a good predictor

---

Departmental Publication (Guidance and Regulation)
Department of Health and Social Care

Mar. 28 2024

Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directions
Document: The General Medical Services Statement of Financial Entitlements (No.2) Directions 2021 (PDF)

Found: payment Claims for payment Information needed by the Board to consider a claim PART 6 Review of Coronavirus

---

Select Committee

Care Quality Commission (CQC)

HMS0018 - Homecare medicines services

Written Evidence Jul. 25 2023

Inquiry: Homecare medicines services
Inquiry Status: Closed
Committee: Public Services Committee

Found: for Health and Social Care] How care homes managed infection prevention and control during the coronavirus

---

Written Question

Coronavirus: Screening and Surveillance

Monday 2nd October 2023

Asked by: Lord Mendelsohn (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the UK Health Security Agency’s observation that “in the UK, the current surveillance systems do not support an assessment of comparative severity between variants”, published on 14 September; and what plans they have to increase PCR testing and COVID-19 surveillance in England.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

Trends in disease severity and outcomes can be monitored over time through hospital data. The UK Health Security Agency (UKHSA) receives vital data from those who are admitted to hospital with symptoms, and UKHSA is using genome sequencing to detect and assess severity and vaccine effectiveness against new variants.

While reduced polymerase chain reaction (PCR) testing in the community limits comparisons of variant severity, surveillance metrics based on current testing continue to provide useful indicators of recent trends.

UKHSA retains laboratory capacity and an ability to scale PCR and lateral flow device testing back up should it be needed.

Planning for the restart of community surveillance for the winter season, when health pressures usually rise, is in progress. A national surveillance report is published every two weeks, and this will increase to once every week in the winter season.

---

Select Committee

King's College London, and King's College London

PRT0058 - Preterm Birth

Written Evidence May. 14 2024

Inquiry: Preterm Birth
Inquiry Status: Closed
Committee: Preterm Birth Committee

Found: The psychological symptoms questions were designed to include the 31 items of the Perinatal Anxiety Screening

---

Non-Departmental Publication (Guidance and Regulation)
UK Health Security Agency

Feb. 19 2024

Source Page: Point prevalence survey on HCAI, AMU and AMS in England
Document: English surveillance programme for antimicrobial utilisation and resistance report 2022 to 2023 (PDF)

Found: CPE screening During 2022, 111 acute trusts reported the results of 420,297 screens for CPE (81% of

---

---

Select Committee

1st Report - Drawn to the special attention of the House: Draft Recognition of Professional Qualifications and Implementation of International Recognition Agreements (Amendment) Regulations 2023, Draft Vehicle Emission Trading Schemes Order 2023 Misuse of Drugs (England and Wales and Scotland) (Amendment) Regulations 2023, Countryside and Rights of Way Act 2000 (Substitution of Cut-off Date Relating to Rights of Way) (England) Regulations 2023; Correspondence: Letter from Rt Hon. Robert Jenrick MP on Home Office breaches of the 21-day rule; Includes information paragraphs on: Draft Health Care Services (Provider Selection Regime) Regulations 2023, Draft Health Protection (Coronavirus, Testing Requirements and Standards) (England) (Amendment and Transitional Provision) Regulations 2023, Draft Plant Health etc. (Miscellaneous Fees) (Amendment) (England) Regulations 2023, Draft Plant Protection Products (Miscellaneous Amendments) Regulations 2023, Draft Representation of the People (Overseas Electors etc.) (Amendment) Regulations 2023 and Draft Representation of the People (Overseas Electors etc.) (Amendment) (Northern Ireland) Regulations 2023 (linked), Draft Sentencing Act 2020 (Amendment of Schedule 21) Regulations 2023, Courts and Tribunals (Fee Remissions and Miscellaneous Amendments) Order 2023, Town and Country Planning (General Permitted Development) (England) (Amendment) Order 2023, Allocation of Housing and Homelessness (Eligibility) (England) and Persons Subject to Immigration Control (Housing Authority Accommodation and Homelessness) (Amendment) (No. 2) Regulations 2023 and Allocation of Housing and Homelessness (Eligibility) (Amendment) (No. 2) Regulations (Northern Ireland) 2023 (linked)

Report Nov. 09 2023

Committee: Secondary Legislation Scrutiny Committee

Found: : Draft Health Care Services (Provider Selection Regime) Regulations 2023, Draft Health Protection (Coronavirus

---

---

Select Committee

Astellas Pharma Ltd.

FCR0037 - Future cancer

Written Evidence Jun. 28 2023

Inquiry: Future cancer
Inquiry Status: Closed
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: recently accepted recommendations made in the EU Cancer Plan for the establishment of national screening

---